Teacher Retirement System of Texas Buys 6,295 Shares of Humana Inc. (NYSE:HUM)

Teacher Retirement System of Texas lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 780.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,102 shares of the insurance provider's stock after purchasing an additional 6,295 shares during the period. Teacher Retirement System of Texas' holdings in Humana were worth $1,802,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Pzena Investment Management LLC increased its holdings in shares of Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares in the last quarter. Boston Partners grew its holdings in shares of Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the last quarter. FMR LLC raised its position in shares of Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the period. Retirement Systems of Alabama lifted its holdings in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new position in shares of Humana in the 3rd quarter valued at $50,102,000. 92.38% of the stock is currently owned by institutional investors.

Remove Ads

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.37% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. StockNews.com downgraded Humana from a "buy" rating to a "hold" rating in a report on Tuesday, March 18th. Morgan Stanley cut their price target on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. JPMorgan Chase & Co. cut their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Finally, Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Eighteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $285.68.

Humana Price Performance

Shares of Humana stock traded down $0.23 during mid-day trading on Monday, reaching $264.35. 1,201,515 shares of the stock were exchanged, compared to its average volume of 1,756,635. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a market cap of $31.91 billion, a price-to-earnings ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The firm has a 50-day simple moving average of $269.77 and a 200 day simple moving average of $273.07. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.